CDH1 and Familial prostate cancer: PCAF-mediated δ-catenin acetylation/destabilization is involved in prostate cancer progression by suppressing E-cadherin processing and β-catenin-mediated oncogenic signals, thereby inhibiting prostate cancer cell motility and tumorigenesis.